Latest Interviews
Showing 1–1 of 1 transcripts.
Clear all filters- All-In Podcast37 min
Juan Carlos Izpisua Belmonte, Altos Labs | All-In Summit 2024
Juan Carlos Izpisua Belmonte, Chamath, Friedberg, Juan Carlos Espucía Belmonte, Juan Carlos Belmonde
Altos Labs, backed by a $3 billion seed investment, is advancing a partial reprogramming strategy that utilizes controlled pulses of Yamanaka factors to reverse aging by restoring closed chromatin conformation without altering the DNA sequence. Early experimental results demonstrate that this approach successfully extends lifespan and reverses specific age-related pathologies in mice and non-human primates, while ex vivo organ treatments show promise for improving transplant viability. With initial clinical applications targeted at acute conditions like liver failure, the company aims to transition from viral vectors to safer, scalable delivery methods to broadly enhance cellular resilience against age-related decline.